retatrutide first week for weight loss: Study shows 30% body weight loss Retatrutide—A Game Changer in Obesity
Description
muciniphila overproliferation leads to excessive mucus layer degradation, compromising intestinal epithelial barrier integrity and promoting bacterial translocation

Reversibility: Medications can be stopped, though weight regain is common

Discuss long-term strategy with your healthcare provider based on your individual response and goals
Nalisa, D

Some people are exceptional responders to semaglutide and may achieve 20%+ loss

As of 2025, retatrutide is still in Phase 3 clinical trials